CXCR4 and acute myeloid leukemia: A study by Möhle et al. showed that leukemic CD34+ blasts from AML patients have considerable amounts of functionally active CXCR4 on their surface what may play a role in regulating the trafficking of malignant cells (Möhle et al., 1998).